Variety of suitable clients: CDEC mentioned the uncertainty in the volume of sufferers with reasonably serious to intense hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical experts consulted by CADTH indicated that some individuals that are categorised as possessing delicate or r